Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases.
Redeker I, Moustakis S, Tsiami S, Baraliakos X, Kiefer D, Andreica I, Buehring B, Braun J, Kiltz U. Redeker I, et al. Among authors: andreica i. Arthritis Res Ther. 2024 Sep 4;26(1):155. doi: 10.1186/s13075-024-03386-7. Arthritis Res Ther. 2024. PMID: 39232829 Free PMC article.
Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging.
Kiefer D, Soltani M, Damirchi P, Kiltz U, Buehring B, Andreica I, Sewerin P, Baraliakos X. Kiefer D, et al. Among authors: andreica i. Arthritis Res Ther. 2024 Jul 25;26(1):138. doi: 10.1186/s13075-024-03377-8. Arthritis Res Ther. 2024. PMID: 39054458 Free PMC article.
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis.
Kiefer D, Schneider L, Braun J, Kiltz U, Kolle N, Andreica I, Tsiami S, Buehring B, Sewerin P, Herbold S, Baraliakos X. Kiefer D, et al. Among authors: andreica i. Ther Adv Musculoskelet Dis. 2024 Feb 22;16:1759720X231224212. doi: 10.1177/1759720X231224212. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 38404654 Free PMC article.
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.
Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, Krickau T, Weller-Heinemann F, Horneff G, Janda A, Foeldvari I, Schuetz C, Dressler F, Borte M, Hufnagel M, Meier F, Fiene M, Andreica I, Weber-Arden J, Blank N. Kuemmerle-Deschner JB, et al. Among authors: andreica i. RMD Open. 2024 Feb 15;10(1):e003890. doi: 10.1136/rmdopen-2023-003890. RMD Open. 2024. PMID: 38360038 Free PMC article.
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.
Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, Andreica I, Kofler DM, Weiner SM, Lamprecht P, Schulze-Koops H, App C, Pournara E, Mendelson MH, Sieder C, Maricos M, Thiel J. Venhoff N, et al. Among authors: andreica i. Lancet Rheumatol. 2023 Jun;5(6):e341-e350. doi: 10.1016/S2665-9913(23)00101-7. Lancet Rheumatol. 2023. PMID: 38251601 Clinical Trial.
43 results